Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 1053-1061

  Chapiro, Jacques ^a   Claverol, Stéphane ^b,c   Piette, Fanny ^a   Ma, Wenbin ^a   Stroobant, Vincent ^a   Guillaume, Benoît ^a   Gairin, Jean Edouard ^b,d   Morel, Sandra ^a,e   Burlet Schiltz, Odile ^b   Monsarrat, Bernard ^b   Boon, Thierry ^a   Van Den Eynde, Benoît J ^a,f  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c Bordeaux Functional Genomic Center   (France)

^d CNRS   (France)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CHYMOTRYPSIN; GLUTAMINE; GLYCINE; GLYCOPROTEIN GP 100; IMMUNOPROTEASOME; LEUCINE; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA ANTIGEN; METHIONINE; MONOPHENOL MONOOXYGENASE; PEPTIDE DERIVATIVE; PHENYLALANINE; PROTEASOME; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ACIDITY; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING;

EID: 30744465074     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.1053     Document Type: Article

References (51)

1. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17: 739-779.
2. Driscoll, J., M. Brown, D. Finley, and J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264.
3. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29: 4037-4042.
4. Morel, S., F. Lévy, O. Burlet-Schiltz, F. Brasseur, M. Probst-Kepper, A.-L. Peitrequin, B. Monsarrat, R. Van Velthoven, J.-C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12; 107-117.
5. Macagno, A., L. Kuehn, R. de Giuli, and M. Groettrup. 2001. Pronounced up-regulation of the PA28αα proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur. J. Immunol. 31: 3271-3280.
6. Nil, A., E. Firat, V. Sobek, K. Eichmann, and G. Niedermann. 2004. Expression of housekeeping and immunoproteasome subunit genes is differentially regulated in positively and negatively selecting thymic stroma subsets. Eur. J. Immunol. 34: 2681-2689.
7. Boes, B., H. Hengel, T. Ruppert, G. Multhaup, U. H. Koszinowski, and P. M. Kloetzel. 1994. Interferonγ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179: 901-909.
8. Groettrup, M., T. Ruppert, L. Kuehn, M. Seeger, S. Standera, U. Koszinowski, and P.-M. Kloetzel. 1995. The interferon-γ-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem. 270: 23808-23815.
9. Gaczynska, M., K. L. Rock, T. Spies, and A. L. Goldberg. 1994. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA 91: 9213-9217.
10. Cardozo, C., and R. A. Kohanski. 1998. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome." J. Biol. Chem. 273: 16764-16770.
11. Gaczynska, M., K. L. Rock, and A. L. Goldberg. 1993. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365: 264-267.
12. Sijts, A. J. A. M., T. Ruppert, B. Rehermann, M. Schmidt, U. Koszinowski, and P.-M. Kloetzel. 2000. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191: 503-513.
13. Sijts, A. J. A. M., S. Standera, R. E. M. Toes, T. Ruppert, N. J. C. M. Beekman, P. A. van Veelen, F. A. Ossendorp, C. J. M. Melief, and P. M. Kloetzel. 2000. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 164: 4500-4506.
14. van Hall, T., A. Sijts, M. Camps, R. Offringa, C. Melief, P.-M. Kloetzel, and F. Ossendorp. 2000. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J. Exp. Med. 192: 483-494.
15. Schwarz, K., M. van den Broek, S. Kostka, R. Kraft, A. Soza, G. Schmidtke, P.-M. Kloetzel, and M. Groettrup. 2000. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28αβ, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J. Immunol. 165: 768-778.
16. Schultz, E. S., J. Chapiro, C. Lurquin, S. Claverol, O. Burlet-Schiltz, G. Warnier, V. Russo, S. Morel, F. Levy, T. Boon, et al. 2002. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J. Exp. Med. 195: 391-399.
17. Gileadi, U., H. T. Moins-Teisserenc, I. Correa, B. L. Booth, Jr., P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163: 6045-6052.
18. Sewell, A. K., D. A. Price, H. Teisserenc, B. L. Booth, Jr., U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162: 7075-7079.
19. Luckey, C. J., G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161: 112-121.
20. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326.
21. Basler, M., N. Youhnovski, M. Van Den Broek, M. Przybylski, and M. Groettrup. 2004. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus. J. Immunol. 173: 3925-3934.
22. Butz, E. A., and M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160: 2139-2144.
23. Arnold, D., J. Driscoll, M. Androlewicz, E. Hughes, P. Cresswell, and T. Spies. 1992. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 360: 171-174.
24. Yewdell, J., C. Lapham, I. Bacik, T. Spies, and J. Bennink. 1994. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol. 152: 1163-1170.
25. Toes, R. E. M., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. N. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Müller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12.
26. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.-H. Meyer zum Büschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764.
27. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wölfel, C. L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183: 527-534.
28. Ma, W., C. Germeau, N. Vigneron, A.-S. Maernoudt, S. Morel, T. Boon, P. G. Coulie, and B. Van den Eynde. 2004. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int. J. Cancer 109: 698-702.
29. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154: 3961-3968.
30. Zarour, H., C. De Smet, F. Lehmann, M. Marchand, B. Leihé, P. Romero, T. Boon, and J.-C. Renauld. 1996. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene PmeI17/gp100. J. Invest. Dermatol. 107: 63-67.
31. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
32. Hendil, K. B., and W. Uerkvitz. 1991. The human multicatalytic proteinase: affinity purification using a monoclonal antibody. J. Biochem. Biophys. Methods 22: 159-165.
33. Saveanu, L., O. Carroll, V. Lindo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697.
34. Groettrup, M., S. Standera, R. Stohwasser, and P. M. Kloetzel. 1997. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94: 8970-8975.
35. Wölfel, C., I. Drexler, A. Van Pel, T. Thres, N. Leister, W. Herr, G. Sutter, C. Huber, and T. Wölfel. 2000. Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope. Int. J. Cancer 88: 432-438.
36. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68: 1015-1068.
37. Reits, E., J. Neijssen, C. Herberts, W. Benckhuijsen, L. Janssen, J. W. Drijfhout, and J. Neefjes. 2004. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
38. Burlet-Schiltz, O., S. Claverol, J.-E. Gairin, and B. Monsarrat. The use of mass spectrometry in the identification of antigens from proteasome processing. Methods Enzymol. In press.
39. Claverol, S., O. Burlet-Schiltz, E. Girbal-Neuhauser, J. E. Gairin, and B. Monsarrat. 2002. Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol. Cell. Proteomics 1: 567-578.
40. Craiu, A., T. Akopian, A. Goldberg, and K. L. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 94: 10850-10855.
41. Rock, K. L., I. A. York, and A. L. Goldberg. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5: 670-677.
42. Nussbaum, A. K., T. P. Dick, W. Keilholz, M. Schirle, S. Stevanovic, W. Dietz, W. Heinemeyer, M. Groll, D. H. Wolf, R. Huber, et al. 1998. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1. Proc. Natl. Acad. Sci. USA 95: 12504-12509.
43. Cascio, P., C. Hilton, A. F. Kisselev, K. L. Rock, and A. L. Goldberg. 2001. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20: 2357-2366.
44. Princiotta, M. F., D. Finzi, S. B. Qian, J. Gibbs, S. Schuchmann, F. Buttgereit, J. R. Bennink, and J. W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
45. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2: 1032-1039.
46. Gotter, J., B. Brors, M. Hergenhahn, and B. Kyewski. 2004. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med. 199: 155-166.
47. Van den Eynde, B. J., and S. Morel. 2001. Differential processing of class-1-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13: 147-153.
48. Nagorsen, D., M. Panelli, M. E. Dudley, S. E. Finkelstein, S. A. Rosenberg, and F. M. Marincola. 2003. Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells. Gene Ther. 10: 1754-1765.
49. + T cells in patients with melanoma. J. Immunol. 164: 3402-3412.
50. Yang, S., D. Kittlesen, C. L. Slingluff, Jr., C. E. Vervaert, H. F. Seigler, and T. L. Darrow. 2000. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J. Immunol. 164: 4204-4211.
51. + T cells: implications for an efficient vaccination strategy. Gene Ther. 10: 243-250.